These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 36129053)
1. To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours. Kam W; Xian Y J Am Heart Assoc; 2022 Oct; 11(19):e027238. PubMed ID: 36129053 [No Abstract] [Full Text] [Related]
2. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke. Zhang B; Sun XJ; Ju CH Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577 [TBL] [Abstract][Full Text] [Related]
3. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase. Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601 [TBL] [Abstract][Full Text] [Related]
6. Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants. Okada T; Yoshimoto T; Wada S; Yoshimura S; Chiba T; Egashira S; Kimura S; Shiozawa M; Inoue M; Ihara M; Toyoda K; Takashima H; Koga M J Am Heart Assoc; 2022 Oct; 11(19):e025809. PubMed ID: 36129032 [TBL] [Abstract][Full Text] [Related]
7. [First case of thrombolysis with non-immunogenic staphylokinase in a patient with ischemic stroke receiving dabigatran etexilate followed by thrombectomy]. Ramazanov GR; Kokov LS; Shamalov NA; Kovaleva EA; Klychnikova EV; Akhmatkhanova LK; Cheboksarov DV; Khamidova LT; Muslimov RS; Rybalko NV; Petrikov SS Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(6):145-151. PubMed ID: 35758961 [TBL] [Abstract][Full Text] [Related]
11. Letter to the Editor Regarding "Intravenous Alteplase in a Patient With Acute Ischemic Stroke Subsequent to Purulent Meningitis". Wong ML; Edlow JA Ann Emerg Med; 2022 Nov; 80(5):474-475. PubMed ID: 36265925 [No Abstract] [Full Text] [Related]
12. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia. Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225 [TBL] [Abstract][Full Text] [Related]
13. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases. Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821 [TBL] [Abstract][Full Text] [Related]
14. Intravenous thrombolysis in stroke patients taking novel oral anticoagulants: experience with the low-dose 0.6 mg/kg of recombinant tissue-type plasminogen activator. Case reports. Plastino M; Bosco D; Giofrè L; Cristiano D; Galati F; Postorino P; Consoli A; Fava A; Consoli D J Neurol Sci; 2018 Oct; 393():24-26. PubMed ID: 30098500 [No Abstract] [Full Text] [Related]
15. Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic Stroke. Faris H; Dewar B; Dowlatshahi D; Ramji A; Kenney C; Page S; Buck B; Hill MD; Coutts SB; Almekhlafi M; Sajobi T; Singh N; Sehgal A; Swartz RH; Menon BK; Shamy M Stroke; 2022 Jul; 53(7):2420-2423. PubMed ID: 35603597 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan. Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC; J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic Strategies for Ischemic Stroke]. Nagata E Brain Nerve; 2023 May; 75(5):450-455. PubMed ID: 37194512 [TBL] [Abstract][Full Text] [Related]
18. In imaging-selected ischemic stroke with unknown onset, alteplase increases favorable outcomes and death at 90 d. Hill MD Ann Intern Med; 2021 Apr; 174(4):JC42. PubMed ID: 33819060 [TBL] [Abstract][Full Text] [Related]
19. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017. Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke. Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]